FDA
-
-
-
-
-
-
-
Revelation Biosciences, Inc. Releases Corporate Update Letter to Stockholders
-
-
-
-
-
-
-
Revelation Biosciences raises $11 million through warrant exercise
-
-
-
-
-
-
-
Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting
-
-
-
-
-
-
-
Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds
-
-
-
-
-
-
-
Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025
-
-
-
-
-
-
-
Revelation Biosciences to Develop Gemini for Infection in Severe Burn Patients
-
-
-
-
-
-
-
Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients
-
327,748 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

